ClinicalTrials.gg
RecruitingNCT05699200Updated Jun 17, 2026

A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection

An interventional study of Arterial Tonometry and Echocardiogram in Spontaneous Coronary Artery Dissection and Healthy, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-17.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Jun 2023; still recruiting 3 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.

Started
2023
the only one that year
No phase
2 of 13
2 open now
Registered
9th of 13
by date
Lead sponsor
8 of 13
Mayo Clinic

Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is the only one that started in 2023, is one of 2 with no phase, and was the 9th registered.

Coronary Artery Dissection, Spontaneous

28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.

Browse Coronary Artery Dissection, Spontaneous studies →

Open to participants now

8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 18 Years and older · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, or all of them as a file.
02

Study summary

The purpose of this research is to compare sympathetic function (flight or fight system) and arterial health including structure and mechanics of participants with history of spontaneous coronary artery dissection (SCAD) to age and sex matched control participants.

03

Conditions studied

  • Spontaneous Coronary Artery Dissection
  • Healthy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • For SCAD patients: history of SCAD as confirmed by coronary angiography or cardiac computed tomography angiography
  • For controls: no cardiac disease history

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Known or suspected unstable cardiac condition within 4 weeks of the study
  • Active treatment with anticoagulation or dual antiplatelet therapy
  • Prisoner
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Other
    Spontaneous coronary artery dissection (SCAD) group

    Subject with a history of SCAD will undergo a series of diagnostic studies to assess neurovascular function.

    Other: Arterial Tonometry · Diagnostic Test: Echocardiogram · Diagnostic Test: Carotid Ultrasounds · Diagnostic Test: Elastography · Other: Ankle-Brachial Index · Other: Microneurography with sympathoexcitatory maneuvers

  • Other
    Healthy Control Group

    Healthy subjects will undergo a series of diagnostic studies to assess neurovascular function.

    Other: Arterial Tonometry · Diagnostic Test: Echocardiogram · Diagnostic Test: Carotid Ultrasounds · Diagnostic Test: Elastography · Other: Ankle-Brachial Index · Other: Microneurography with sympathoexcitatory maneuvers

Interventions

  • OtherArterial Tonometry

    We will measure arterial stiffness using arterial tonometry.

  • Diagnostic testEchocardiogram

    We will collect limited ultrasound images of the heart.

  • Diagnostic testCarotid Ultrasounds

    We will perform ultrasound imaging of the carotid artery.

  • Diagnostic testElastography

    We will measure the elastic properties of the arteries using elastography.

  • OtherAnkle-Brachial Index

    We will measure the ankle-brachial index to assess peripheral artery blood flow.

  • OtherMicroneurography with sympathoexcitatory maneuvers

    We will measure sympathetic nerve activity at rest and in response to isometric handgrip, mental stress test, cold pressor test, Valsalva maneuvers.

06

What researchers measure

Primary outcomes

  1. Arterial thickness

    Measured by carotid ultrasound intimal media thickness reporting in mm

    Time frame: Baseline

  2. Arterial stiffness

    Measured by carotid ultrasound pulse wave velocity reporting in m/s

    Time frame: Baseline

  3. Baroreflex sensitivity

    The slope between heart rate and blood pressure at rest and during the Valsalva Maneuver (ms/mmHg)

    Time frame: Baseline

  4. Sympathetic response to stress

    Blood pressure or muscle sympathetic nerve activity response to sympathoexcitatory stressors (mm/Hg or bursts/min).

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2023 (actual). Primary completion is estimated for Aug 2027, 50 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 16, 2023
First posted
Jan 26, 2023
StartActual
Jun 1, 2023
Primary completionEst.
Aug 2027
CompletionEst.
Aug 2027
Last update
Jun 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05699200
Lead sponsor
Mayo Clinic
Responsible party
Marysia Tweet (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Jan 26, 2023
Start date
Jun 1, 2023
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Jun 17, 2026

Study contacts

Pamela Engrav
Contact
Engrav.Pamela@mayo.edu
507-255-6938
Marysia Tweet, MD, MS
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion